Zhang S, Ehlers M D, Bernhardt J P, Su C T, Huganir R L
Department of Neuroscience, Howard Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Neuron. 1998 Aug;21(2):443-53. doi: 10.1016/s0896-6273(00)80553-x.
Ca2+ influx through N-methyl-D-aspartate (NMDA) receptors activates signal transduction pathways critical for many forms of synaptic plasticity in the brain. NMDA receptor-mediated Ca2+ influx also downregulates the gating of NMDA channels through a process called Ca2+-dependent inactivation (CDI). Recent studies have demonstrated that the calcium binding protein calmodulin directly interacts with NMDA receptors, suggesting that calmodulin may play a role in CDI. We report here that the mutation of a specific calmodulin binding site in the CO region of the NR1 subunit of the NMDA receptor blocks CDI. Moreover, intracellular infusion of a calmodulin inhibitory peptide markedly reduces CDI of both recombinant and neuronal NMDA receptors. Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1. Taken together, these results demonstrate that the binding of Ca2+/calmodulin to NR1 mediates CDI of the NMDA receptor and suggest that inactivation occurs via Ca2+/calmodulin-dependent release of the receptor complex from the neuronal cytoskeleton.
通过N-甲基-D-天冬氨酸(NMDA)受体的Ca2+内流激活了对大脑中多种形式突触可塑性至关重要的信号转导通路。NMDA受体介导的Ca2+内流还通过一种称为钙依赖性失活(CDI)的过程下调NMDA通道的门控。最近的研究表明,钙结合蛋白钙调蛋白直接与NMDA受体相互作用,提示钙调蛋白可能在CDI中发挥作用。我们在此报告,NMDA受体NR1亚基CO区域中一个特定的钙调蛋白结合位点的突变会阻断CDI。此外,细胞内注入钙调蛋白抑制肽可显著降低重组和神经元NMDA受体的CDI。此外,通过共表达已知与NR1的CO区域相互作用的细胞骨架蛋白α-辅肌动蛋白2的一个区域,可以防止钙调蛋白的这种失活作用。综上所述,这些结果表明Ca2+/钙调蛋白与NR1的结合介导了NMDA受体的CDI,并提示失活是通过Ca2+/钙调蛋白依赖性地使受体复合物从神经元细胞骨架中释放而发生的。